Welcome to LookChem.com Sign In|Join Free

CAS

  • or

116047-26-8

Post Buying Request

116047-26-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-Naphthalenecarboxylic acid, 5,6,7,8-tetrahydro-8-oxo-, methyl ester/ LIDE PHARMA- Factory supply / Best price

    Cas No: 116047-26-8

  • USD $ 10.0-10.0 / Gram

  • 1 Gram

  • 10 Metric Ton/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier

116047-26-8 Usage

Description

Methyl 8-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate is a chemical compound with a molecular formula of C13H14O3. It is categorized as a monocarboxylic acid ester and an organic oxide. Methyl 8-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate can also be classified as a derivative of a tetralin—an organic compound consisting of a benzene ring fused with a cyclohexane ring. This particular chemical is often referenced in scientific literature for its synthetic applications in chemistry.

Uses

Used in Chemical Synthesis:
Methyl 8-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure and reactivity make it a valuable component in the synthesis of complex molecules, particularly in the fields of pharmaceuticals and materials science.
Used in Research Applications:
Methyl 8-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate is used as a research compound for studying the properties and reactions of monocarboxylic acid esters and organic oxides. Its potential applications in niche areas of chemistry and material science are being explored, contributing to the advancement of scientific knowledge in these fields.

Check Digit Verification of cas no

The CAS Registry Mumber 116047-26-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,0,4 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 116047-26:
(8*1)+(7*1)+(6*6)+(5*0)+(4*4)+(3*7)+(2*2)+(1*6)=98
98 % 10 = 8
So 116047-26-8 is a valid CAS Registry Number.

116047-26-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 8-oxo-6,7-dihydro-5H-naphthalene-2-carboxylate

1.2 Other means of identification

Product number -
Other names 7-Methoxycarbonyl-1,2,3,4-tetrahydronaphthalen-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:116047-26-8 SDS

116047-26-8Downstream Products

116047-26-8Relevant articles and documents

ANTIDIABETIC TRICYCLIC COMPOUNDS

-

Page/Page column 116, (2015/12/08)

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR 40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds may be useful in the treatment of Type 2 diabetes mellitus and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

ALKYNYL ARYL CARBOXAMIDES

-

Page/Page column 55, (2008/06/13)

The present invention is related to alkynyl aryl carboxamides of Formula (I’) and use thereof for the treatment and/or prevention of an inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance. insulin resistance, hyperlipidemia, hypertriglyceridemia- hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of alkynyl aryl carboxamides of Formula (I’) to modulate, notably to inhibit the activity of PTPs. (I’) A is a C2-C15 alkynyl, C2-C6-alkynyl aryl, C2-C6-alkynyl heteroaryl. Cy is an aryl, heteroaryl, cycloalkyl or heterocycle group; n is either 0 or 1. Cy' is an aryl., which may optionally be fused by a 3-8 membered cycloalkyl. R1and R2 are independently from each other is selected from the group consisting of hydrogen or (CI-C6)alkyl. R4and R5 are each independently from each other selected from the group consisting of H, hydroxy. C1 -C6 alkyl, carboxy, C1-C6 alkoxy, C1 -C3 alkyl carboxy, C2-C3 alkenyl carboxy, C2-C3 alkynyl carboxy, amino or R4 and R5 may form an unsaturated or saturated heterocyclic ring, whereby at least one of R4 or R5 is not a hydrogen or C1-C6 alkyl.

The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x)

Murphy, Paul V.,Hubbard, Rod E.,Manallack, David T.,Wills, Ruth E.,Montana, John G.,Taylor, Richard J. K.

, p. 2421 - 2439 (2007/10/03)

The design and synthesis of a series of analogues of sialyl Lewis(x) (1) which incorporate conformationally rigid tetralin and naphthalene ring systems (2-4) has led to novel compounds which have similar potency to 1 as inhibitors of cell adhesion. Copyright (C) 1998 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116047-26-8